Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia
  • Sodium content of processed foods in the United Kingdom: analysis of 44,000 foods purchased by 21,000 households

    The American Journal of Clinical Nutrition Date published:
  • Comparison of Near-Patient Capillary Glucose Measurement and a Risk Assessment Questionnaire in Screening for Type 2 Diabetes in a High-Risk Population in Rural India

    Diabetes Care Date published:
  • Nutrient content of products served by leading Australian fast food chains

    Appetite Date published:
  • Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

    American Heart Journal Date published:
  • Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage

    Hypertension Date published:
  • Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes

    Journal of the American College of Cardiology Date published:
  • Monitoring Adherence to Medication by Measuring Change in Blood Pressure

    Hypertension Date published:
  • Severe Hypoglycemia and Risks of Vascular Events and Death

    New England Journal of Medicine Date published:
  • Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis

    Intensive Care Medicine Date published:
  • Erratum

    The American Journal of Clinical Nutrition Date published:
  • Effects Of Internet-Based Tailored Advice on the Use of Cholesterol-Lowering Interventions: A Randomized Controlled Trial

    Journal of Medical Internet Research Date published:
  • Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens

    Hypertension Date published:
  • Effects of fibrates on cardiovascular outcomes - Authors' reply

    The Lancet Date published:
  • The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

    Diabetes Research and Clinical Practice Date published:
  • Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

    Diabetologia Date published:
  • Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk

    BMC Public Health Date published: